INVISTA 70MG TABLET

Form: Tablets

Pack Size: 10 TABLETS

Marketed by: DR. REDDY'S LABORATORIES LTD (ONCOLOGY DIV)

MRP: ₹875.43

DR. REDDY'S LABORATORIES LTD (ONCOLOGY DIV): Invista 70MG Tablet, 10 tablets, salt dasatinib 70mg. NPPA has revised its MRP from Rs 1,056 to Rs 875.43 (17% lower) with effect from 09-11-2026; trade rate Rs 666.99. Group: BCR-ABL tyrosine kinase inhibitor (targeted therapy). Same salt is also supplied by Cipla, Hetero, Torrent. Handling/counselling: avoid antacids within 2 hours; check co-prescriptions for PPIs. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.